Diabetes and cardiovascular disease. The Framingham study - PubMed (original) (raw)
Diabetes and cardiovascular disease. The Framingham study
W B Kannel et al. JAMA. 1979.
Abstract
Based on 20 years of surveillance of the Framingham cohort relating subsequent cardiovascular events to prior evidence of diabetes, a twofold to threefold increased risk of clinical atherosclerotic disease was reported. The relative impact was greatest for intermittent claudication (IC) and congestive heart failure (CHF) and least for coronary heart disease (CHD), which was, nevertheless, on an absolute scale the chief sequela. The relative impact was substantially greater for women than for men. For each of the cardiovascular diseases (CVD), morbidity and mortality were higher for diabetic women than for nondiabetic men. After adjustment for other associated risk factors, the relative impact of diabetes on CHD, IC, or stroke incidence was the same for women as for men; for CVD death and CHF, it was greater for women. Cardiovascular mortality was actually about as great for diabetic women as for diabetic men.
Similar articles
- Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
Wannamethee SG, Shaper AG, Lennon L. Wannamethee SG, et al. Heart. 2004 Dec;90(12):1398-403. doi: 10.1136/hrt.2003.026104. Heart. 2004. PMID: 15547012 Free PMC article. - Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.
Brand FN, Abbott RD, Kannel WB. Brand FN, et al. Diabetes. 1989 Apr;38(4):504-9. doi: 10.2337/diab.38.4.504. Diabetes. 1989. PMID: 2925008 - Update on some epidemiologic features of intermittent claudication: the Framingham Study.
Kannel WB, McGee DL. Kannel WB, et al. J Am Geriatr Soc. 1985 Jan;33(1):13-8. doi: 10.1111/j.1532-5415.1985.tb02853.x. J Am Geriatr Soc. 1985. PMID: 3965550 - Diabetes mellitus and coronary heart disease.
Wilson PW. Wilson PW. Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S89-100. doi: 10.1053/ajkd.1998.v32.pm9820468. Am J Kidney Dis. 1998. PMID: 9820468 Review. - Cardiovascular risk in women with diabetes.
Rivellese AA, Riccardi G, Vaccaro O. Rivellese AA, et al. Nutr Metab Cardiovasc Dis. 2010 Jul;20(6):474-80. doi: 10.1016/j.numecd.2010.01.008. Nutr Metab Cardiovasc Dis. 2010. PMID: 20621459 Review.
Cited by
- ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts.
Yang N, Zhang R, Zhang H, Yu Y, Xu Z. Yang N, et al. Cardiovasc Diabetol. 2024 Nov 7;23(1):399. doi: 10.1186/s12933-024-02499-2. Cardiovasc Diabetol. 2024. PMID: 39511569 Free PMC article. - Leveraging calcium score CT radiomics for heart failure risk prediction.
Singh P, Hoori A, Freeze J, Hu T, Tashtish N, Gilkeson R, Li S, Rajagopalan S, Wilson DL, Al-Kindi S. Singh P, et al. Sci Rep. 2024 Nov 6;14(1):26898. doi: 10.1038/s41598-024-77269-x. Sci Rep. 2024. PMID: 39505933 Free PMC article. - Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice.
Keever K, Askari B. Keever K, et al. Curr Res Pharmacol Drug Discov. 2024 Oct 10;7:100203. doi: 10.1016/j.crphar.2024.100203. eCollection 2024. Curr Res Pharmacol Drug Discov. 2024. PMID: 39497763 Free PMC article. - Potential pathogenic roles of ferroptosis and cuproptosis in cadmium-induced or exacerbated cardiovascular complications in individuals with diabetes.
Saedi S, Tan Y, Watson SE, Wintergerst KA, Cai L. Saedi S, et al. Front Endocrinol (Lausanne). 2024 Oct 2;15:1461171. doi: 10.3389/fendo.2024.1461171. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39415790 Free PMC article. Review. - Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature.
Tiwari D, Aw TC. Tiwari D, et al. Diagnostics (Basel). 2024 Oct 9;14(19):2251. doi: 10.3390/diagnostics14192251. Diagnostics (Basel). 2024. PMID: 39410655 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources